View Older Stories View More Recent Stories
-
Enzon Pharmaceuticals (ENZN) Suspends Clinical Development, To Explore a Sale
-
Cytori (CYTX) Prices 7.02M Offering at $2.85/Share
-
Sarepta Therapeutics (SRPT) 4.95M Share Offering Priced at $25.25
-
Sarepta Therapeutics (SRPT) Announces Common Stock Offering
-
Lazard (LAZ) Declares $0.20 Special Dividend; 0.6% Yield
-
Lazard (LAZ) Declares $0.20 Quarterly Dividend; 2.6% Yield
-
Notable Analyst Rating Changes 12/11: (CNX) (CBI) (MNST) Upgraded; (CBL) (ARW) (LPL) Downgraded
-
Lazard Capital Downgrades Foster Wheeler (FWLT) to Neutral
-
Lazard Capital Upgrades Chicago Bridge & Iron (CBI) to Buy
-
Notable Analyst Rating Changes 12/10: (TRIP) (ANF) (SWFT) Upgraded; (GTI) (CME) (X) Downgraded
-
Lazard Capital Starts Ruckus Wireless (RKUS) at Buy
-
Lazard Capital Downgrades McGraw-Hill (MHP) to Hold
-
Lazard Capital Cuts PT on Amarin (AMRN) to $16
-
Lazard Capital Starts ON Semi (ONNN) at Neutral
-
Lazard Capital Starts Atmel (ATML) at Neutral
-
NovaBay Pharma (NBY) Prices 5.9M Common Offering at $1.25/Share
-
NovaBay Pharma (NBY) Announces Common Offering
-
Lazard Capital Starts Supernus Pharmaceuticals (SUPN) at Buy
-
Lazard Capital Starts Covanta (CVA) at Buy
-
CreXus Investment (CXS) Taps Lazard to Advise on Annaly (NLY) Bid
-
Raymond James Starts Lazard (LAZ) at Outperform
-
Analysts, Physicians Positive on FDA Approval of Exelixis' (EXEL) Cabozantinib into Meeting
-
Notable Analyst Rating Changes 11/26: (RIMM) (YHOO) (FB) Upgraded; (MCD) (ARO) (ILMN) Downgraded
-
Lazard Capital Downgrades McDonald's (MCD) to Neutral
-
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
Lazard Capital Upgrades Penn National Gaming (PENN) to Buy
-
Lazard Capital Starts WellPoint (WLP) at Neutral
-
Lazard Capital Starts UnitedHealth Group (UNH) at Buy
-
Lazard Capital Starts Aetna (AET) at Buy
-
CNH Global (CNH) Affirms Fiat Industrial Bid; Will Review Proposal
-
Notable Mergers and Acquisitions of the Day 11/16: (PENN) (SHF) (OUTD) (HTZ)/(DTG) More...
-
Outdoor Channel (OUTD) Enters Merger with InterMedia Outdoors
-
Stocks Crossing 50-Day SMA 11/13: (DVAX) (ARNA) (DKS) Above; (CELG) (ALU) (PMT) Below
-
Notable Analyst Rating Changes 11/13: (ALB) (EV) (DDD) Upgraded; (MCP) (LYB) (JNS) Downgraded
-
Lazard Capital Starts Berry Plastics Group (BERY) at Buy
-
Unusual 11 Mid-Day Movers 11/12: (TIE) (STV) (LDK) Higher; (GALE) (CLVS) (STSI) Lower
-
Sarepta (SRPT) Trades Higher on Eteplirsen Phase II Update, Analyst Comments
-
Lazard Capital Downgrades Kayak Software (KYAK) to Neutral
-
Lazard Capital Downgrades Progenics Pharmaceuticals (PGNX) to Neutral
-
Lazard Capital Downgrades STEC, Inc. (STEC) to Neutral
-
Lazard Capital Upgrades Demandware (DWRE) to Buy
-
Lazard Capital Starts Kythera Biopharmaceuticals (KYTH) at Buy
-
MSCI (MSCI) Unit to Acquire IPD Group in $125M Deal
-
Notable Analyst Rating Changes 10/26: (CSTR) (CME) (PG) Upgraded; (CLF) (CAT) (CTCT) Downgraded
-
Lazard Capital Downgrades Starwood Hotels & Resorts (HOT) to Neutral
-
Lazard Capital Upgrades Varian Medical (VAR) to Buy
-
Lazard Capital Downgrades Constant Contact (CTCT) to Neutral
-
Lazard (LAZ) Tops Q3 EPS by 4c
-
Lazard Capital Downgrades TriQuint Semiconductor (TQNT) to Neutral
-
Trading Radar for 10/25: Apple (AAPL), Sprint (S), Amazon (AMZN), Clearwire (CLWR), Procter & Gamble (PG), Dunkin' Brands (DNKN), Expedia (EXPE) Report

